According to the World Health Organization (WHO) classification, glioblastoma multiforme (GBM) is categorized into two subtypes based on genetic characteristics, specifically the presence or absence of isocitrate dehydrogenase (IDH) mutations: IDH‐mutant and IDH‐wild type [9, 10]. The gene discussed is IDH1; the disease is glioblastoma.